WebApr 10, 2024 · MS is Still Biogen’s Top Earner. During the investor call, Viehbacher said the MS franchise still supports most of Biogen’s revenue. In 2024, Biogen’s MS business earned $5.43 billion dollars, accounting for nearly 68% of the company’s full-year revenue. Still, at constant currencies, MS sales dropped 9% from the year prior due to ... WebFeb 15, 2024 · The medicine’s benefits are modest — it slowed cognitive decline by 27 percent in an 18-month clinical study run by the Japanese drug firm Eisai and its Cambridge partner Biogen — but hopes ...
Why Biogen Stock Is On Fire Today The Motley Fool
WebNov 30, 2024 · On today's stock market, Biogen stock jumped 4.7% to 305.17. Eisai stock leapt 8.3% to 70.10. ... Related news Biogen Pops — But Ionis Hands Back Gains — After ALS Drug Wins A Key Endorsement. WebMar 23, 2024 · Biogen has applied important learnings to its portfolio of assets for genetic and other forms of ALS, with the goal of increasing the probability of bringing a potential … black and decker mulcher blower
BIIB News Today Why did Biogen stock go up today? - MarketBeat
WebApr 12, 2024 · CAMBRIDGE, Mass. and SOUTH SAN FRANCISCO, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that Biogen has exercised the option to license Denali’s Antibody Transport Vehicle (ATV):Amyloid beta program (ATV:Aß). Accumulation of Aß plaque in … WebMar 30, 2024 · CAMBRIDGE, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (NASDAQ: BIIB) today announced the appointment of Chuck Triano as Senior Vice President, Head of Investor Relations effective 10 April 2024. Mr. Triano will report to Michael McDonnell, Executive Vice President and Chief Financial. A Statement from … WebApr 11, 2024 · Cambridge, Mass.— Biogen Inc. (Nasdaq:BIIB) today announced it will report first quarter 2024 financial results Tuesday, April 25, 2024, before the financial … dave and busters terms of use